NCT01136109

Brief Summary

Previous research has shown that the Inferior Vena Cava Collapsibility Index (IVCCI) can be used to assess volume status. One limitation of the previous work is that changes in intra-thoracic pressure can influence this measurement, and the magnitude of this effect has never been described. The investigators aim is to correlate the degree of change in IVCCI with the set degree of change in intra-thoracic pressure in a heterogeneous population of critically ill patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2009

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

May 26, 2010

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 3, 2010

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2013

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

3.3 years

First QC Date

May 26, 2010

Last Update Submit

March 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Determine the effect of an increase in positive end-expiratory pressure on intrathoracic pressure variables in patients with acute respiratory failure.

    1. Determine the effect on inferior vena cava collapsibility index of an increase in positive end-expiratory pressure (and resultant change in mean airway pressure) in patients with acute respiratory failure. 2. Determine the effect on central venous pressure of an increase in positive end-expiratory pressure (and resultant change in mean airway pressure) in patients with acute respiratory failure. 3. Determine the effect on mean airway pressure of an increase in positive end-expiratory pressure in patients with acute respiratory failure.

    24 months

Secondary Outcomes (2)

  • Determine the inter-rater reliability in obtaining inferior vena cava collapsibility index ultrasound images.

    24 months

  • Determine the relationship between central venous pressure and inferior vena cava collapsibility index at varying levels of mean airway pressure (MAP).

    24 Months

Study Arms (2)

Bedside ultrasound only

Bedside ultrasound to determine the dimensions of the inferior vena cava

Ultrasound with ventilator changes

Bedside ultrasound to determine the dimensions of the inferior vena cava pre and post ventilator changes.

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

InpatientSample

You may qualify if:

  • Age\>17 years
  • Current use of mechanical ventilation through an endotracheal tube.
  • Admitted to ICU within last 48 hours

You may not qualify if:

  • Severe COPD by history (documented FEV1\<50% predicted or CT evidence of emphysema)
  • Current suspected Asthma Exacerbation
  • Profound Hypoxia defined as a FiO2 requirement \>90% or a PEEP \>10 mmHg
  • Patient-ventilator desynchrony or active agitation
  • Unstable O2 requirement as determined by the primary clinical team.
  • Prisoners
  • Bedside clinician refusal (physician or treating nurse).
  • Cardiovascular instability (any increase in rate of vasopressors or i.v. fluid bolus for hypotension within the last four hours)
  • Current PEEP requirements of \>15cmH2O
  • Current SpO2 of \<88%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43221, United States

Location

MeSH Terms

Conditions

Respiratory Insufficiency

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract Diseases

Study Officials

  • Naeem Ali, M.D.

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor-Clinical

Study Record Dates

First Submitted

May 26, 2010

First Posted

June 3, 2010

Study Start

October 1, 2009

Primary Completion

February 1, 2013

Study Completion

February 1, 2013

Last Updated

March 5, 2024

Record last verified: 2024-03

Locations